Covid drug hopeful turns to biotech vet who sold last company for $1 billlion March 4, 2022 San Francisco Biotechnology Network News News Comments Off on Covid drug hopeful turns to biotech vet who sold last company for $1 billlion The company hopes to start a Phase II/III trial of its potential Covid-19 drug in the middle part of this year. Click to view original post